Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol plus remifentanil versus propofol plus remifentanil in pediatric ambulatory surgery
ChiCTR2600134993Phase 4Not yet recruiting
- Sponsor
- Beijing Children's Hospital
- Start
- Oct 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ciprofol, propofol and remifentanil (3 arms), sponsored by Beijing Children's Hospital. Primary endpoint: Time from drug discontinuation to recovery of anesthesia. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
ciprofolpropofolremifentanil
Beyond the preview
Go deeper on ChiCTR2600134993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600134993.